3107B |
Nabumetone as Metabolite, Blood |
3107SP |
Nabumetone as Metabolite, Serum/Plasma |
3107U |
Nabumetone as Metabolite, Urine |
3110B |
Nalbuphine - Free (Unconjugated), Blood |
3110SP |
Nalbuphine - Free (Unconjugated), Serum/Plasma |
3110U |
Nalbuphine - Total (Conjugated/Unconjugated), Urine |
3130B |
Naproxen, Blood |
3130FL |
Naproxen, Fluid |
3130SP |
Naproxen, Serum/Plasma |
3130U |
Naproxen, Urine |
3150B |
Nicotine and Metabolite, Blood |
3150FL |
Nicotine and Metabolite, Fluid |
3150SP |
Nicotine and Metabolite, Serum/Plasma |
3150TI |
Nicotine and Metabolite, Tissue |
3150U |
Nicotine and Metabolite with Anabasine, Urine |
3168B |
Nitazenes Panel, Blood |
3218B |
N,N-Dimethylpentylone & Pentylone, Blood |
3218SP |
N,N-Dimethylpentylone & Pentylone, Serum/Plasma |
3218U |
N,N-Dimethylpentylone & Pentylone, Urine |
3223SP |
Nonsteroidal Anti-Inflammatory Drug Panel, Serum/Plasma |
3224B |
NPS Stimulants (Qualitative), Blood |
3224SP |
NPS Stimulants (Qualitative), Serum/Plasma |
3224U |
NPS Stimulants (Qualitative), Urine |
8054B |
NMS TotalTox™ Panel, Blood (Forensic) Overview: Forensic Analysis; Exclusion Screen; This test is New York State approved. |
8756B |
Novel Psychoactive Substances (NPS) Screen 1, Blood |
8756SP |
Novel Psychoactive Substances (NPS) Screen 1, Serum/Plasma |
8756U |
Novel Psychoactive Substances (NPS) Screen 1, Urine |
9404B |
Nicotine and Metabolite Screen, Blood |
9404SP |
Nicotine and Metabolite Screen, Serum/Plasma |
9404U |
Nicotine and Metabolite with Anabasine Screen, Urine |